$5.59
+0 (+0%)
At Close: Jul 20, 2022
Antares Pharma reports Q4 EPS 3c, consensus 0c ATRS
12:02pm, Tuesday, 03'rd Mar 2020
Antares Pharma reports Q4 EPS 3c, consensus 0c ATRS
Antares Pharma Reports Fourth Quarter and Full Year 2019 Operating and Financial Results
12:00pm, Tuesday, 03'rd Mar 2020
Record Quarterly Revenue of $37.8 Million – Earnings Per Share of $0.03 Record Annual Revenue of $123.9 Million, a 95% Increase over 2018 Annual Revenue EWING, N.J., March.
Antares Pharma Reports Fourth Quarter and Full Year 2019 Operating and Financial Results
12:00pm, Tuesday, 03'rd Mar 2020
Record Quarterly Revenue of $37.8 Million – Earnings Per Share of $0.03 Record Annual Revenue of $123.9 Million, a 95% Increase over 2018 Annual Revenue ...
Seabury Capital Advises Aurelius on Acquisition of German Aircraft Seat Manufacturer Zim Flugsitz
01:49pm, Monday, 02'nd Mar 2020
Seabury Capital advises Aurelius on the acquisition of German manufacturer Zim Flugsitz, marking Aurelius’ entry into the aircraft interior niche.
Health Check: How Prudently Does Antares Pharma (NASDAQ:ATRS) Use Debt?
02:20pm, Sunday, 01'st Mar 2020
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Sign In
Buy ATRS